🇺🇸 FDA
Pipeline program

INXN-2001

ADA1001

Phase 2 mab completed

Quick answer

INXN-2001 for Melanoma is a Phase 2 program (mab) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Alaunos Therapeutics
Indication
Melanoma
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials